Danièle Weerts
- Epidemiology top 10%
- Pharmacology top 5%
- Oncology top 10%
- Infectious Diseases top 10%
- Molecular Medicine top 5%
- Co-authors
- Jean KlášterskýD. DaneauNathan ClumeckStéphane De WitHerman GoossensColette HensgensL DebusscherJean‐Paul Sculier
- Topics
- Neutropenia and Cancer Infections (7 papers)Bacterial Identification and Susceptibility Testing (4 papers)Antibiotic Resistance in Bacteria (4 papers)
- Partner nations
- Belgium
In The Last Decade
Danièle Weerts
14 papers receiving 694 citations
Peers
Comparison fields: 5 of 85
- Epidemiology 335
- Pharmacology 238
- Oncology 237
- Infectious Diseases 219
- Molecular Medicine 154
Countries citing papers authored by Danièle Weerts
This map shows the geographic impact of Danièle Weerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danièle Weerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danièle Weerts more than expected).
Fields of papers citing papers by Danièle Weerts
This network shows the impact of papers produced by Danièle Weerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danièle Weerts. The network helps show where Danièle Weerts may publish in the future.
Co-authorship network of co-authors of Danièle Weerts
This figure shows the co-authorship network connecting the top 25 collaborators of Danièle Weerts. A scholar is included among the top collaborators of Danièle Weerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danièle Weerts. Danièle Weerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 20 | |
| 2 | 167 | |
| 3 | 86 | |
| 4 | 46 | |
| 5 | Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party. | 25 |
| 6 | 17 | |
| 7 | 3 | |
| 8 | 196 | |
| 9 | 95 | |
| 10 | Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains. | 55 |
| 11 | 40 | |
| 12 | 28 | |
| 13 | 7 | |
| 14 | 13 |
About Danièle Weerts
Danièle Weerts is a scholar working on Molecular Medicine, Clinical Biochemistry and Oncology, having authored 14 papers that have together received 798 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (7 papers), Bacterial Identification and Susceptibility Testing (4 papers) and Antibiotic Resistance in Bacteria (4 papers). The work is most often cited by research in Molecular Medicine (154 citations), Clinical Biochemistry (151 citations) and Applied Microbiology and Biotechnology (42 citations). Danièle Weerts has collaborated with scholars based in Belgium. Frequent co-authors include Jean Klášterský, D. Daneau, Nathan Clumeck, Stéphane De Wit, Herman Goossens, Colette Hensgens, L Debusscher, Jean‐Paul Sculier, M. Piccart and F. Meunier. Their work appears in journals such as The Lancet, CHEST Journal and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.